Wissenschaftliche Publikationen 2017 - Kantonsspital St.Gallen
←
→
Transkription von Seiteninhalten
Wenn Ihr Browser die Seite nicht korrekt rendert, bitte, lesen Sie den Inhalt der Seite unten
Wissenschaftliche Publikationen 2017
Inhaltsverzeichnis
Departement I ........................................................................................................... 4
Allgemeine Innere Medizin/Hausarztmedizin ........................................................................... 4
Angiologie ............................................................................................................................... 4
Endokrinologie/Diabetologie.................................................................................................... 4
Gastroenterologie/Hepatologie................................................................................................ 5
Infektiologie/Spitalhygiene ...................................................................................................... 6
Kardiologie .............................................................................................................................. 8
Onkologie/Hämatologie ......................................................................................................... 10
Pneumologie/Schlafmedizin .................................................................................................. 16
Psychosomatik ...................................................................................................................... 18
Rheumatologie ...................................................................................................................... 18
Departement II ........................................................................................................ 20
Anästhesiologie/Intensivmedizin ........................................................................................... 20
Klinik für Allgemein-, Viszeral-, Endokrin- und Transplantationschirurgie .............................. 21
Klinik für Gefässchirurgie ...................................................................................................... 22
Frauenklinik .......................................................................................................................... 23
Klinik für Orthopädische Chirurgie ......................................................................................... 24
Klinik für Urologie .................................................................................................................. 25
Departement III ....................................................................................................... 27
Augenklinik ........................................................................................................................... 27
Hals-Nasen-Ohrenklinik ........................................................................................................ 27
Neurochirurgie ...................................................................................................................... 27
Neurologie ............................................................................................................................ 29
Departement IV ....................................................................................................... 31
Pathologie ............................................................................................................................. 31
Radiologie und Nuklearmedizin ............................................................................................. 32
Radio-Onkologie ................................................................................................................... 33
Rechtsmedizin ...................................................................................................................... 34
Departement Interdisziplinäre Med. Dienste ........................................................ 35
Zentrale Notfallaufnahme ...................................................................................................... 35
Dermatologie/Allergologie ..................................................................................................... 35
Brustzentrum ........................................................................................................................ 37
Muskelzentrum/ALS clinic ..................................................................................................... 38
Institut für Immunbiologie ...................................................................................................... 39
Clinical Trials Unit ................................................................................................................. 40
Palliativzentrum..................................................................................................................... 41
Seite 1 von 41Kantonsspital St.Gallen – Publikationen
Am Kantonsspital St.Gallen wird klinische 400
Anzahl Publikationen
Forschung und translationale
Grundlagenforschung auf hohem Niveau 300
betrieben. Die Ergebnisse der Studien und
Forschungsprojekte werden an 200
wissenschaftlichen Kongressen präsentiert
100
und in wissenschaftlichen Journalen
publiziert. Um die Öffentlichkeit und die 0
Fachwelt über die Forschungsaktivitäten am 2015 2016 2017
Kantonsspital St.Gallen zu informieren,
werden die Publikationen in der Forschungs- Journale ohne Impact Factor
und Studiendatenbank systematisch erfasst Journale mit Impact Factor
und ausgewertet (www.forschung.kssg.ch).
Abb.1. Anzahl der Publikationen in
Im Jahr 2017 wurden 372 Publikationen mit
Journalen mit oder ohne Impact-Factor in
Beteiligung von Forschenden des
den Jahren 2015 – 2017
Kantonsspitals St.Gallen veröffentlicht. Von
diesen Arbeiten wurden 303 in Journalen mit 350 6.5 7.0
Impact-Factor publiziert (Abb. 1). Der Publikationen mit Impact-Factor 300 6.0
Impact-Factor einer Fachzeitschrift gibt an, 5.1
Impact/Publikation [■]
4.8
wie oft ein Artikel aus dieser Zeitschrift von 250 5.0
anderen Forschenden zitiert wird. Für die
200 4.0
Berechnung des mittleren Impact-Faktors
der Publikationen des Kantonsspital 150 3.0
St.Gallen, wurden Daten des Journal 100 2.0
Citation Reports aus dem Jahr 2016
verwendet. 50 1.0
258 323 303
Erneut konnten über 300 wissenschaftliche 0 0.0
Arbeiten in Zeitschriften mit Impakt-Faktor 2015 2016 2017
publiziert werden. Besonders erfreulich ist,
Abb.2. Mittlere Qualität der Publikationen
dass der mittlere Impact-Factor pro
gemessen als durchschnittlicher Impact-
Publikation auf 6.5 gestiegen ist. In Abb. 2
Factor pro Veröffentlichung
sind die Daten der Jahre 2015-2017 gezeigt.
Die Auswertung der Publikationsdaten nach 200
Anzahl Publikationen
Medizinischen Departementen zeigt (Abb. 175
150
3), dass in allen Disziplinen intensiv
125
geforscht und publiziert wird. Grosse
100
Departemente, wie die Innere Medizin 75
(Med.Dept. I), steuern den Grossteil der 50
Publikationen bei. In Abbildung 3 ist die 25
Publikationstätigkeit der Jahre 2015 – 2017 0
15 16 17 15 16 17 15 16 17 15 16 17 15 16 17
in den einzelnen Departementen gezeigt. Dept. I Dept. II Dept. III Dept. IV IMD
Detaillierte Auswertungen können beim
Medizinischen Forschungszentrum (MFZ) In Journalen ohne Impact Factor
angefordert werden. In Journalen mit Impact Factor
Abb. 3. Publikationsstatistik in den
Departementen I-IV und IMD in den Jahren
2015-2017
Seite 2 von 41Die Publikationen wurden direkt aus der Forschungs- und Studiendatenbank des KSSG extrahiert
(www.forschung.kssg.ch). Für die Vollständigkeit und Richtigkeit der Publikationen in der
Datenbank tragen die Fachbereiche die Verantwortung. Durch Anklicken des Bereichs/Instituts
wird man direkt auf die Publikationen in der Datenbank verlinkt.
Seite 3 von 41Departement I
Allgemeine Innere Medizin/Hausarztmedizin
Wissenschaftliche Artikel
1. Brändle M, Büche D, Nestor K. Hilfe beim Sterben, Hilfe zum Sterben oder Hilfe zum Leben?
Sterbehilfe rechtlich, ethisch und palliativ betrachtet. Schweiz Med Forum 2017 2017; 17:738-
743.
2. Brenner R, Diethelm M, Maeder M T. Blutdruck und akutes Koronarsyndrom – Pathophysiologie,
Prognose und Therapie. LEADING OPTIONS Innere Medizin 2017; 2017:18-20.
3. Dicker M, Schneider T, von Kempis J, Diethelm M. [A Rare Differential Diagnosis of Chronic
Cough]. Dtsch Med Wochenschr 2017; 142:1751-1755.
4. Henz S, tapernoux d, Diethelm M, Bucher C, Fehr T, Propp S. Einfluss von Postmenopause,
Sonnenlichtexposition, Arzneimitteln und Komorbiditätenauf Serumkalzium und Phosphat bei
13.000 Krankenhauspatienten*. Nieren- und Hochdruckkrankheiten 2017; 46:1-8.
5. Quarella M, Walser D, Brändle M, Fournier J Y, Bilz S. Rapid Onset of Diabetic Ketoacidosis
After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly. J Clin Endocrinol Metab
2017; 102:1451-1453.
6. Streuli R, Krull I, Brändle M, Kolb W, Stalla G, Theodoropoulou M, Enzler-Tschudy A, Bilz S. A
rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing's
disease. Endocrinol Diabetes Metab Case Rep 2017; 2017: 17-0058.
Angiologie
Wissenschaftliche Artikel
1. Benecke U, Koeger P. Blue-Finger-Syndrome and Tofacitinib. Annale of Clinical Case Reports -
Rheumatology 2017; 2:
Endokrinologie/Diabetologie
Wissenschaftliche Artikel
1. Brändle M, Büche D, Nestor K. Hilfe beim Sterben, Hilfe zum Sterben oder Hilfe zum Leben?
Sterbehilfe rechtlich, ethisch und palliativ betrachtet. Schweiz Med Forum 2017 2017; 17:738-
743.
2. Ding M, Huang T, Bergholdt H K, Nordestgaard B G, Ellervik C, Qi L, Renström F. Dairy
consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study.
BMJ 2017; 356:j1000.
3. Graff M, Scott R A, Justice A E, et al. Genome-wide physical activity interactions in adiposity - A
meta-analysis of 200,452 adults. PLoS Genet 2017; 13:e1006528.
4. Justice A E, Winkler T W, Feitosa M F, et al. Genome-wide meta-analysis of 241,258 adults
accounting for smoking behaviour identifies novel loci for obesity traits. Nat Commun 2017;
8:14977.
5. Liu D J, Peloso G M, Yu H, et al. Exome-wide association study of plasma lipids in >300,000
individuals. Nat Genet 2017; 49:1758-1766.
6. Marouli E, Graff M, Medina-Gomez C, et al. Rare and low-frequency coding variants alter human
adult height. Nature 2017; 542:186-190.
7. Quarella M, Walser D, Brändle M, Fournier J Y, Bilz S. Rapid Onset of Diabetic Ketoacidosis
After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly. J Clin Endocrinol Metab
2017; 102:1451-1453.
8. Streuli R, Krull I, Brändle M, Kolb W, Stalla G, Theodoropoulou M, Enzler-Tschudy A, Bilz S. A
Seite 4 von 41rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing's
disease. Endocrinol Diabetes Metab Case Rep 2017; 2017: 17-0058.
9. Tognon G, Nilsson L M, Shungin D, Lissner L, Jansson J H, Renström F, Wennberg M, Winkvist
A, Johansson I. Nonfermented milk and other dairy products: associations with all-cause
mortality. Am J Clin Nutr 2017; 105:1502-1511.
10. Tümer Z, Petris M, Zhu S, Mercer J, Bukrinski J, Bilz S, Baerlocher K, Horn N, Møller L B. A 37-
year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key
factors in beneficial treatment. Clin Genet 2017; 92:548-553.
11. van Duijnhoven F J B, Jenab M, Hveem K, Siersema P D, Fedirko V, Duell E J, Kampman E,
Halfweeg A, van Kranen H J, van den Ouweland J M W, Weiderpass E, Murphy N, Langhammer
A, Ness-Jensen E, Olsen A, Tjønneland A, Overvad K, Cadeau C, Kvaskoff M, Boutron-Ruault M
C, Katzke V A, Kühn T, Boeing H, Trichopoulou A, Kotanidou A, Kritikou M, Palli D, Agnoli C,
Tumino R, Panico S, Matullo G, Peeters P, Brustad M, Olsen K S, Lasheras C, Obón-Santacana
M, Sánchez M J, Dorronsoro M, Chirlaque M D, Barricarte A, Manjer J, Almquist M, Renström F,
Ye W, Wareham N, Khaw K T, Bradbury K E, Freisling H, Aune D, Norat T, Riboli E, Bueno-de-
Mesquita H B. Circulating concentrations of vitamin D in relation to pancreatic cancer risk in
European populations. Int J Cancer 2017 [Epub ahead of print]
12. Vines L, Frick T, Aczel S, L'Allemand D, Borovicka J, Schiesser M. Linear stapled
gastrojejunostomy results in fewer strictures compared to circular stapled gastrojejunostomy in
laparoscopic gastric bypass surgery. Langenbecks Arch Surg 2017 [Epub ahead of print]
13. Winkvist A, Klingberg S, Nilsson L M, Wennberg M, Renström F, Hallmans G, Boman K,
Johansson I. Longitudinal 10-year changes in dietary intake and associations with cardio-
metabolic risk factors in the Northern Sweden Health and Disease Study. Nutr J 2017; 16:20.
Gastroenterologie/Hepatologie
Wissenschaftliche Artikel
1. Bernsmeier C, Albano E. Liver dendritic cells and NAFLD evolution: A remaining open issue. J
Hepatol 2017; 66:1120-1122.
2. Bernsmeier C, Triantafyllou E, Brenig R, Lebosse F J, Singanayagam A, Patel V C, Pop O T,
Khamri W, Nathwani R, Tidswell R, Weston C J, Adams D H, Thursz M R, Wendon J A,
Antoniades C G. CD14+CD15-HLA-DR- myeloid-derived suppressor cells impair antimicrobial
responses in patients with acute-on-chronic liver failure. Gut 2017;.
3. Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A,
Razavi H, Schmid P, Semela D, Stoeckle M, Negro F. Hepatitis C virus dynamics among
intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the
disease by 2030. Swiss Med Wkly 2017; 147:w14543.
4. Fraga M, Doerig C, Moulin H, Bihl F, Brunner F, Müllhaupt B, Ripellino P, Semela D, Stickel F,
Terziroli Beretta-Piccoli B, Aubert V, Telenti A, Greub G, Sahli R, Moradpour D. Hepatitis E virus
as a cause of acute hepatitis acquired in Switzerland. Liver Int 2017;.
5. Gauthiez E, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M,
George J, Heim M H, Malinverni R, Moradpour D, Müllhaupt B, Negro F, Semela D, Semmo N,
Villard J, Bibert S, Bochud P Y, Swiss Hepatitis C Cohort Study . A systematic review and meta-
analysis of HCV clearance. Liver Int 2017; 37:1431-1445.
6. Greuter T, Vavricka S R, Biedermann L, Pilz J, Borovicka J, Seibold F, Sauter B, Rogler G.
Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-
Sided Ulcerative Colitis and Ulcerative Proctitis. Dig Dis 2017;.
7. Keiser O, Giudici F, Müllhaupt B, Junker C, Dufour J F, Moradpour D, Bruggmann P, Terziroli B,
Semela D, Brezzi M, Bertisch B, Estill J, Negro F, Spoerri A, Swiss Hepatitis C Cohort Study and
the Swiss National Cohort . Trends in hepatitis C-related mortality in Switzerland. J Viral Hepat
2017; 25:152-160.
8. Khamri W, Abeles R D, Hou T Z, Anderson A E, El-Masry A, Triantafyllou E, Bernsmeier C,
Seite 5 von 41Larsen F S, Singanayagam A, Kudo N, Possamai L A, Lebosse F, Auzinger G, Bernal W, Willars
C, Weston C J, Lombardi G, Wendon J, Thursz M, Antoniades C G. Increased Expression of
CTLA4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute
Liver Failure. Gastroenterology 2017;.
9. Kolly P, Waidmann O, Vermehren J, Moreno C, Vögeli I, Berg T, Semela D, Zeuzem S, Dufour J
F. Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European
multicentre study. J Hepatol 2017; 67:876-878.
10. Lenggenhager D, Gouttenoire J, Malehmir M, Bawohl M, Honcharova-Biletska H, Kreutzer S,
Semela D, Neuweiler J, Hürlimann S, Aepli P, Fraga M, Sahli R, Terracciano L, Rubbia-Brandt L,
Müllhaupt B, Sempoux C, Moradpour D, Weber A. Visualization of hepatitis E virus RNA and
proteins in the human liver. J Hepatol 2017; 67:471-479.
11. Marti L, Galata C, Beutner U, Hetzer F, Pipitone N, Wolff K, Borovicka J, Brunner W, Sulz M,
Maurus C. Percutaneous tibial nerve stimulation (pTNS): success rate and the role of rectal
capacity. Int J Colorectal Dis 2017; 32:789-796.
12. Terziroli Beretta-Piccoli B, Stirnimann G, Cerny A, Semela D, Hessler R, Helbling B, Stickel F,
Kalid-de Bakker C, Bihl F, Giostra E, Filipowicz Sinnreich M, Oneta C, Baserga A, Invernizzi P,
Carbone M, Mertens J. Geoepidemiology of Primary Biliary Cholangitis: Lessons from
Switzerland. Clin Rev Allergy Immunol 2017;.
13. Török H P, Bellon V, Konrad A, Lacher M, Tonenchi L, Siebeck M, Brand S, De Toni E N.
Functional Toll-Like Receptor (TLR)2 polymorphisms in the susceptibility to inflammatory bowel
disease. PLoS ONE 2017; 12:e0175180.
14. Triantafyllou E, Pop O T, Possamai L A, Wilhelm A, Liaskou E, Singanayagam A, Bernsmeier C,
Khamri W, Petts G, Dargue R, Davies S P, Tickle J, Yuksel M, Patel V C, Abeles R D, Stamataki
Z, Curbishley S M, Ma Y, Wilson I D, Coen M, Woollard K J, Quaglia A, Wendon J, Thursz M R,
Adams D H, Weston C J, Antoniades C G. MerTK expressing hepatic macrophages promote the
resolution of inflammation in acute liver failure. Gut 2017;.
15. Vavricka S R, Spasojevic M, Rogler G, Schoepfer A M, Seibold F, Borovicka J, Frei P, Zeitz J,
Greuter T, Manser C, Scharl M, Misselwitz B, Straumann A, Michetti P, Biedermann L,. Long-
Term Efficacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population:
The FACTS III Survey. Dig Dis 2017; 35:423-432.
16. Vines L, Frick T, Aczel S, L'allemand D, Borovicka J, Schiesser M. Linear stapled
gastrojejunostomy results in fewer strictures compared to circular stapled gastrojejunostomy in
laparoscopic gastric bypass surgery. Langenbecks Arch Surg 2017;.
Infektiologie/Spitalhygiene
Wissenschaftliche Artikel
1. Albrich W, Huttner B D, Huttner A. Validation of IDSA/ATS Algorithm for Duration of Pneumonia
Therapy. JAMA Intern Med 2017; 177:283-284.
2. Bayard C, Ledergerber B, Flepp M, Lecompte T, Moulin E, Hoffmann M, Weber R, Staehelin C,
Di Benedetto C, Fux C A, Tarr P E, Hasse B, Swiss HIV Cohort Study. Associations Between
Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study. Open
Forum Infect Dis 2017; 4:ofx177.
3. Béguelin C, Friolet N, Moradpour D, Sahli R, Suter-Riniker F, Lüthi A, Cavassini M, Günthard H
F, Battegay M, Bernasconi E, Schmid P, Calmy A, Atkinson A, Rauch A, Wandeler G,. Impact of
tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study. Clin Infect Dis 2017;.
4. Béguelin C, Suter A, Bernasconi E, Fehr J, Kovari H, Bucher H C, Stoeckle M, Cavassini M,
Rougemont M, Schmid P, Wandeler G, Rauch A, Swiss HIV Cohort Study . Trends in HCV
treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study. Liver Int
2017;.
5. Böni C, Al-Sheikh M, Hasse B, Eberhard R, Kohler P, Hasler P, Erb S, Hoffmann M, Barthelmes
D, Zweifel S A. MULTIMODAL IMAGING OF CHOROIDAL LESIONS IN DISSEMINATED
Seite 6 von 41MYCOBACTERIUM CHIMAERA INFECTION AFTER CARDIOTHORACIC SURGERY. Retina
(Philadelphia, Pa) 2017;.
6. Borges H, Hoy J, Florence E, Sedlacek D, Stellbrink H J, Uzdaviniene V, Tomazic J, Gargalianos-
Kakolyris P, Schmid P, Orkin C, Pedersen C, Leen C, Pradier C, Mulcahy F, Ridolfo A L, Staub T,
Maltez F, Weber R, Flamholc L, Kyselyova G, Lundgren J D, Mocroft A. Antiretrovirals, Fractures,
and Osteonecrosis in a Large International HIV Cohort. Clin Infect Dis 2017; 64:1413-1421.
7. Carreño J M, Perez Shibayama C, Gil Cruz C, López-Macías C, Vernazza P, Ludewig B, Albrich
W. Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in
humans following oral Ty21a vaccination: A randomized clinical trial. PLoS ONE 2017;
12:e0178669.
8. Combes J D, Clifford G M, Egger M, Cavassini M, Hirsch H H, Hauser C, Calmy A, Schmid P,
Bernasconi E, Günthard H F, Franceschi S, Waterboer T, Scherrer A U, Swiss HIV Cohort Study.
Human papillomavirus antibody response following HAART initiation among MSM. AIDS 2017;
31:561-569.
9. Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C, Kirk O, Sambatakou H,
Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J,
Rozentale B, Radoi R, Losso M H, Lundgren J D, Mocroft A, EuroSIDA Study Group . Incidence
of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-
raltegravir-based combination antiretroviral therapy regimens. HIV Med 2017;.
10. Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr
J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille
J, Lamoth F, Marchetti O, Bochud P Y, Fungal Infection Network of Switzerland (FUNGINOS) .
Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.
Intensive Care Med 2017; 43:935-939.
11. Elzi L, Erb S, Furrer H, Cavassini M, Calmy A, Vernazza P, Günthard H, Bernasconi E, Battegay
M,. Adverse events of raltegravir and dolutegravir. AIDS 2017; 31:1853-1858.
12. Feigelman R, Kahlert C R, Baty F, Rassouli F, Kleiner R L, Kohler P, Brutsche M, von Mering C.
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to
pathogen details. Microbiome 2017; 5:20.
13. Gebreselassie H M, Kraus D, Fux C A, Haubitz S, Scherrer A, Hatz C, Veit O, Stoeckle M, Fehr J,
de Lucia S, Cavassini M, Bernasconi E, Schmid P, Furrer H, Staehelin C,. Ethnicity predicts viral
rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort
Study. HIV Med 2017;.
14. Huttner A, Albrich W, Bochud P Y, Gayet-Ageron A, Rossel A, Dach E v, Harbarth S, Kaiser L.
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing
overuse of antibiotic therapy in Gram-negative bacteraemia. BMJ Open 2017; 7:e017996.
15. Kohler P, Volling C, Green K, Uleryk E M, Shah P S, McGeer A. Carbapenem Resistance, Initial
Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and
Meta-Analysis. Infect Control Hosp Epidemiol 2017;1-10.
16. Lapointe-Shaw L, Voruganti T, Kohler P, Thein H H, Sander B, McGeer A. Cost-effectiveness
analysis of universal screening for carbapenemase-producing Enterobacteriaceae in hospital
inpatients. Eur J Clin Microbiol Infect Dis 2017; 36:1047-1055.
17. Marzel A, Shilaih M, Turk T, Campbell N K, Yang W L, Böni J, Yerly S, Klimkait T, Aubert V,
Furrer H, Calmy A, Battegay M, Cavassini M, Bernasconi E, Schmid P, Metzner K J, Günthard H
F, Kouyos R D,. Mining for pairs: shared clinic visit dates identify steady HIV-positive
partnerships. HIV Med 2017;.
18. Mayer L M, Kahlert C R, Rassouli F, Vernazza P, Albrich W. Impact of viral multiplex real-time
PCR on management of respiratory tract infection: a retrospective cohort study. Pneumonia
(Nathan) 2017; 9:4.
19. Ruppen C, Notter J, Strahm C, Sonderegger B, Sendi P. Osteoarticular and skin and soft-tissue
infections caused by Streptococcus agalactiae in elderly patients are frequently associated with
bacteremia. Diagn Microbiol Infect Dis 2017; 90:55-57.
Seite 7 von 4120. Salazar-Vizcaya L, Kouyos R D, Fehr J, Braun D, Estill J, Bernasconi E, Delaloye J, Stöckle M,
Schmid P, Rougemont M, Wandeler G, Günthard H F, Keiser O, Rauch A, Swiss HIV Cohort
Study . On the potential of a short-term intensive intervention to interrupt HCV transmission in
HIV-positive men who have sex with men: A mathematical modelling study. J Viral Hepat 2017;
25:10-18.
21. Sculier D, Gayet-Ageron A, Battegay M, Cavassini M, Fehr J, Hirzel C, Schmid P, Bernasconi E,
Calmy A, Swiss HIV Cohort Study . Rilpivirine use in the Swiss HIV cohort study: a prospective
cohort study. BMC Infect Dis 2017; 17:476.
22. Shilaih M, Marzel A, Braun D L, Scherrer A U, Kovari H, Young J, Calmy A, Darling K, Battegay
M, Hoffmann M, Bernasconi E, Thurnheer M C, Günthard H F, Kouyos R D,. Factors associated
with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine
(Baltimore) 2017; 96:e5849.
23. Sommerstein R, Kohler P, Hasse B. Global Mycobacterium chimaera outbreak: challenges for the
near future. J Hosp Infect 2017; 96:207-208.
24. Strahm C, Albrich W, Zdravkovic V, Schöbi B, hildebrandt g, Schlegel M. Infection Rate after
Cranial Neurosurgical Procedures: A Prospective Single-Center Study. World Neurosurg 2017;.
25. Turk T, Bachmann N, Kadelka C, Böni J, Yerly S, Aubert V, Klimkait T, Battegay M, Bernasconi
E, Calmy A, Cavassini M, Furrer H, Hoffmann M, Günthard H F, Kouyos R D, Swiss HIV Cohort
Study , Aubert V, Battegay M, Bernasconi E, Böni J, Braun D L, Bucher H C, Calmy A, Cavassini
M, Ciuffi A, Dollenmaier G, Egger M, Elzi L, Fehr J, Fellay J, Furrer H, Fux C A, Günthard H F,
Haerry D, Hasse B, Hirsch H H, Hoffmann M, Hösli I, Kahlert C R, Kaiser L, Keiser O, Klimkait T,
Kouyos R D, Kovari H, Ledergerber B, Martinetti G, Martinez de Tejada B, Marzolini C, Metzner K
J, Müller N, Nicca D, Pantaleo G, Paioni P, Rauch A, Rudin C, Scherrer A U, Schmid P, Speck R,
Stöckle M, Tarr P, Trkola A, Vernazza P, Wandeler G, Weber R, Yerly S. Assessing the danger of
self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
Elife 2017; 6:.
26. Zumstein V, Betschart P, Albrich W, Buhmann M, Ren Q, Schmid H P, Abt D. biofilm formation on
ureteral stents. Swiss Med Forum 2017; 17 (7):174.
27. Zumstein V, Betschart P, Albrich W, Buhmann M T, Ren Q, Schmid H P, Abt D. Biofilm formation
on ureteral stents - Incidence, clinical impact, and prevention. Swiss Med Wkly 2017; 147:w14408
Kardiologie
Wissenschaftliche Artikel
1. Blum S, Muff C, Aeschbacher S, Ammann P, Erne P, Moschovitis G, di Valentino M, Shah D,
Schläpfer J, Fischer A, Merkel T, Kühne M, Sticherling C, Osswald S, Conen D. Prospective
Assessment of Sex-Related Differences in Symptom Status and Health Perception Among
Patients With Atrial Fibrillation. J Am Heart Assoc 2017; 6:.
2. Boehnel C, Rickli H, Graf L, Maeder M T. Coronary angiography with or without percutaneous
coronary intervention in patients with hemophilia-Systematic review. Catheter Cardiovasc Interv
2017;.
3. Brenner R, Ammann P, Yoon S I, Christen S, Hellermann J, Girod G, Knaus U, Duru F, Krasniqi
N, Ramsay D, Sticherling C, Lippuner K, Kühne M. Reduction of falls and fractures after
permanent pacemaker implantation in elderly patients with sinus node dysfunction. Europace
2017; 19:1220-1226.
4. Brenner R, Diethelm M, Maeder M T. Blutdruck und akutes Koronarsyndrom – Pathophysiologie,
Prognose und Therapie. LEADING OPTIONS Innere Medizin 2017; 2017:18-20.
5. Burri H, Müller H, Kobza R, Sticherling C, Ammann P, Zerlik H, Stettler C, Klersy C, Prinzen F,
Auricchio A. RIght VErsus Left Apical transvenous pacing for bradycardia: Results of the RIVELA
randomized study. Indian Pacing Electrophysiol J 2017; 17:171-175.
6. Conen D, Rodondi N, Mueller A, Beer J, Auricchio A, Ammann P, Hayoz D, Kobza R, Moschovitis
G, Shah D, Schlaepfer J, Novak J, di Valentino M, Erne P, Sticherling C, Bonati L, Ehret G, Roten
Seite 8 von 41L, Fischer U, Monsch A, Stippich C, Wuerfel J, Schwenkglenks M, Kuehne M, Osswald S. Design
of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive
decline among patients with atrial fibrillation. Swiss Med Wkly 2017; 147:w14467.
7. Davarzani N, Sanders-van Wijk S, Karel J, Maeder M T, Leibundgut G, Gutmann M, Pfisterer M
E, Rickenbacher P, Peeters R, Brunner-La Rocca H P. N-Terminal Pro-B-Type Natriuretic
Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results
From TIME-CHF. J Card Fail 2017; 23:382-389.
8. Fournier S, Muller O, Benedetto U, Roffi M, Pilgrim T, Eberli F R, Rickli H, Radovanovic D, Erne
P, Cook S, Noble S, Fesselet R, Zuffi A, Degrauwe S, Masci P, Windecker S, Eeckhout E,
Iglesias J F, on behalf on the AMIS Plus Investigators . Circadian dependence of manual
thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction
undergoing primary percutaneous coronary intervention. Clin Res Cardiol 2017;.
9. Jeger R V, Pfister O, Radovanovic D, Eberli F R, Rickli H, Urban P, Pedrazzini G, Stauffer J C,
Nossen J, Erne P, AMIS-Plus Investigators . Heart failure in patients admitted for acute coronary
syndromes: A report from a large national registry. Clin Cardiol 2017; 40:907-913.
10. Knecht S, Burch F, Reichlin T, Spies F, Mühl A, Altmann D, Ammann P, Schaer B, Osswald S,
Sticherling C, Kühne M. First clinical experience of a dedicated irrigated-tip radiofrequency
ablation catheter for the ablation of cavotricuspid isthmus-dependent atrial flutter. Clin Res
Cardiol 2017;.
11. Maeder M T, König T, Bogdanovic S, Schneider I, Eugster W, Ammann P, König M, Beer J, Rickli
H. Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation - real-
life data from a survey in Eastern Switzerland. Swiss Med Wkly 2017; 147:w14503.
12. Maeder M T, Nägele R, Rohner P, Weilenmann D. Pulmonary hypertension in stiff left atrial
syndrome: pathogenesis and treatment in one. ESC Heart Fail 2017;.
13. Maeder M T, Thompson B R, Kaye D M. Inverse Association Between Myocardial B-Type
Natriuretic Peptide Release and Functional Capacity in Healthy Humans. Heart Lung Circ 2017;.
14. Nanayakkara S, Haykowsky M, Mariani J, van Empel V, Maeder M T, Vizi D, Kaye D M.
Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by
Age. J Am Heart Assoc 2017; 6:.
15. Radovanovic D, Seifert B, Roffi M, Urban P, Rickli H, Pedrazzini G, Erne P. Gender differences in
the decrease of in-hospital mortality in patients with acute myocardial infarction during the last 20
years in Switzerland. Open Heart 2017; 4:e000689.
16. Reusser A, Blum S, Aeschbacher S, Eggimann L, Ammann P, Erne P, Moschovitis G, Di
Valentino M, Shah D, Schläpfer J, Manser S, Reichlin T, Kühne M, Sticherling C, Osswald S,
Conen D. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation. Int J
Cardiol 2017; 252:101-105.
17. Rickenbacher P, Kaufmann B A, Maeder M T, Bernheim A, Goetschalckx K, Pfister O, Pfisterer
M, Brunner-La Rocca H P. Heart failure with mid-range ejection fraction: a distinct clinical entity?
Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with
Congestive Heart Failure (TIME-CHF). Eur J Heart Fail 2017;.
18. Rigamonti F, Fahrni G, Maeder M T, Cook S, Weilenmann D, Wenaweser P, Röthlisberger C,
Corti R, Rickli H, Kaiser C, Roffi M. Switzerland: coronary and structural heart interventions from
2010 to 2015. EuroIntervention 2017; 13:Z75-Z79.
19. Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D. Treatment of patients with myocardial
infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care
2017;2048872617729636.
20. Schreglmann S R, Bauer R, Hägele-Link S, Bhatia K P, Natchev P, Wegener N, Abbühl D,
Werner B, Martin E, Kägi G. Unilateral cerebellothalamic tract ablation in essential tremor by MRI-
guided focused ultrasound. Neurology 2017;.
21. Taramasso M, Denegri A, Kuwata S, Rickli H, Haager P K, Sütsch G, Rodriguez Cetina Biefer H,
Kottwitz J, Nietlispach F, Maisano F. Feasibility and safety of transfemoral sheathless portico
aortic valve implantation: Preliminary results in a single center experience. Catheter Cardiovasc
Interv 2017; 91:533-539.
Seite 9 von 4122. Zimny M, Blum S, Ammann P, Erne P, Moschovitis G, di Valentino M, Shah D, Schläpfer J, Vogt
C, Tabord A, Kühne M, Sticherling C, Osswald S, Conen D. Uptake of non-vitamin K antagonist
oral anti coagulants in patients with atrial fibrillation - a prospective cohort study. Swiss Med Wkly
2017; 147:w14410.
Nephrologie/Transplantationsmedizin
Wissenschaftliche Artikel
1. Burkhalter F, Huynh-Do U, Hadaya K, Matter M, Müller T, Binet I, Nolte C, Steiger J. Early
complications after living donor nephrectomy: analysis of the Swiss Organ Living Donor Health
Registry. Swiss Med Wkly 2017; 147:w14497.
2. Burkhalter H, Denhaerynck K, Huynh-Do U, Binet I, Hadaya K, De Geest S, Psychosocial Interest
Group, Swiss Transplant Cohort Study . Change of sleep quality from pre- to 3 years post-solid
organ transplantation: The Swiss Transplant Cohort Study. PLoS ONE 2017; 12:e0185036.
3. Glatz N, Chappuis A, Conen D, Erne P, Péchère-Bertschi A, Guessous I, Forni V, Gabutti L,
Muggli F, Gallino A, Hayoz D, Binet I, Suter P, Paccaud F, Bochud M, Burnier M. Associations of
sodium, potassium and protein intake with blood pressure and hypertension in Switzerland. Swiss
Med Wkly 2017; 147:w14411.
4. Henz S, tapernoux d, Diethelm M, Bucher C, Fehr T, Propp S. Einfluss von Postmenopause,
Sonnenlichtexposition, Arzneimitteln und Komorbiditätenauf Serumkalzium und Phosphat bei
13.000 Krankenhauspatienten*. Nieren- und Hochdruckkrankheiten 2017; 46:1-8.
5. Leboeuf C, Wilk S, Achermann R, Binet I, Golshayan D, Hadaya K, Hirzel C, Hoffmann M,
Huynh-Do U, Koller M T, Manuel O, Mueller N J, Mueller T F, Schaub S, van Delden C,
Weissbach F H, Hirsch H H, Swiss Transplant Cohort Study . BK Polyomavirus-Specific 9mer
CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients:
First Report From the Swiss Transplant Cohort Study. Am J Transplant 2017; 17:2591-2600.
6. Saigi-Morgui N, Quteineh L, Bochud P Y, Crettol S, Kutalik Z, Mueller N J, Binet I, van Delden C,
Steiger J, Mohacsi P, Dufour J F, Soccal P M, Pascual M, Eap C B, Swiss Transplant Cohort
Study . Genetic and clinic predictors of new onset diabetes mellitus after transplantation.
Pharmacogenomics J 2017;.
Onkologie/Hämatologie
Bücher
1. Renz M: Eo tteoh ge jug eum eul ma ju hal geos in ga [Hinübergehen] : a leum da un ma mu li
leul wi han im jong hag gang ui. Seoul : Chaek-Se-Sang Pub. Co., 2017.- ISBN 979-11-5931-
110-9
2. Renz M: Erlösung aus Prägung : Ein neues Verständnis von Heilung. Psychologie und Theologie
im Gespräch. Paderborn : Junfermann, 2017.- ISBN 978-3-95571-406-2
3. Renz M: Hinübergehen : Was beim Sterben geschieht. Annäherungen an letzte Wahrheiten
unseres Lebens. 2. Aufl.. Freiburg i.Br. : Herder, 2017.- ISBN 978-3-451-06788-4
Wissenschaftliche Artikel
1. Abt D, Besse A, Sedlarikova L, Kraus M, Bader J, Silzle T, Vodinska M, Slaby O, Schmid H P,
Engeler D S, Driessen C, Besse L. Improving the efficacy of proteasome inhibitors in the
treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-
protease inhibitors lopinavir or nelfinavir. BJU Int 2017;.
2. Arends J, Baracos V, Bertz H, Bozzetti F, Calder P C, Deutz N E P, Erickson N, Laviano A,
Lisanti M P, Lobo D N, McMillan D C, Muscaritoli M, Ockenga J, Pirlich M, Strasser F, de van der
Schueren M, Van Gossum A, Vaupel P, Weimann A. ESPEN expert group recommendations for
action against cancer-related malnutrition. Clin Nutr 2017;.
Seite 10 von 413. Baraniskin A, Van Laethem J L, Wyrwicz L, Gueller U, Wasan H S, Matysiak-Budnik T,
Gruenberger T, Ducreux M, Carneiro F, Van Cutsem E, Seufferlein T, Schmiegel W. Clinical
relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive
Oncology (ESDO) expert discussion and recommendations from the 17th European Society for
Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona. Eur J Cancer
2017; 86:305-317.
4. Bartlett J M S, Ahmed I, Regan M M, Sestak I, Mallon E A, Dell'orto P, Thürlimann B, Seynaeve
C, Putter H, Van de Velde C J H, Brookes C L, Forbes J F, Viale G, Cuzick J, Dowsett M, Rea D
W. HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients
from ATAC, BIG 1-98 and TEAM with centrally determined HER2. Eur J Cancer 2017; 79:129-
138.
5. Baty F, Joerger M, Früh M, Klingbiel D, Zappa F, Brutsche M. 24h-gene variation effect of
combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using
exon array blood profiling. J Transl Med 2017; 15:66.
6. Bernard M, Strasser F, Gamondi C, Braunschweig G, Forster M, Kaspers-Elekes K, Veri S W,
Borasio G D. Relationship between spirituality, meaning in life, psychological distress, wish for
hastened death, and their influence on quality of life in palliative care patients. J Pain Symptom
Manage 2017;.
7. Besse A, Stolze S C, Rasche L, Weinhold N, Morgan G J, Kraus M, Bader J, Overkleeft H S,
Besse L, Driessen C. Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome
by nelfinavir and lopinavir in multiple myeloma. Leukemia 2017; 32:391-401.
8. Besse L, Kraus M, Besse A, Bader J, Silzle T, Mehrling T, Driessen C. The first-in-class alkylating
HDAC inhibitor EDO-S101 is highly synergistic with proteasome inhibition against multiple
myeloma through activation of multiple pathways. Blood Cancer J 2017; 7:e589.
9. Borchmann P, Goergen H, Kobe C, Lohri A, Greil R, Eichenauer D A, Zijlstra J M, Markova J,
Meissner J, Feuring-Buske M, Hüttmann A, Dierlamm J, Soekler M, Beck H J, Willenbacher W,
Ludwig W D, Pabst T, Topp M S, Hitz F, Bentz M, Keller U B, Kühnhardt D, Ostermann H,
Schmitz N, Hertenstein B, Aulitzky W, Maschmeyer G, Vieler T, Eich H, Baues C, Stein H, Fuchs
M, Kuhnert G, Diehl V, Dietlein M, Engert A. PET-guided treatment in patients with advanced-
stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised
phase 3 trial by the German Hodgkin Study Group. Lancet 2017; 390:2790-2802.
10. Borgquist S, Giobbie-Hurder A, Ahern T P, Garber J E, Colleoni M, Láng I, Debled M, Ejlertsen B,
von Moos R, Smith I, Coates A S, Goldhirsch A, Rabaglio M, Price K N, Gelber R D, Regan M M,
Thürlimann B. Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in
the BIG 1-98 Study. J Clin Oncol 2017; 35:1179-1188.
11. Bossi P, siano m, Bergamini C, Cossu Rocca M, Sponghini A P, Giannoccaro M, Tonella L, Paoli
A, Marchesi E, Perrone F, Pilotti S, Locati L D, Canevari S, Licitra L, De Cecco L. Are Fusion
Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to
Anti-EGFR Therapies? Dis Markers 2017; 2017:6870614.
12. Burmeister K, Quagliata L, Andreozzi M, Eppenberger-Castori S, Matter M S, Perrina V, Grobholz
R, Jochum W, Horber D, Moosmann P, Lehmann F, Köberle D, Ng C K Y, Piscuoglio S, Tornillo
L, Terracciano L M. Vascular endothelial growth factor A amplification in colorectal cancer is
associated with reduced M1 and M2 macrophages and diminished PD-1-expressing
lymphocytes. PLoS ONE 2017; 12:e0175563.
13. Burmeister K, Quagliata L, Andreozzi M, Eppenberger-Castori S, Matter M, Perrina V, Grobholz
R, Jochum W, Horber D, Moosmann P, Lehmann F, Koeberle D, Ng C, Piscuoglio S, Tornillo L,
Terracciano L. Vascular endothelial growth factor A amplification in colorectal cancer is
associated with reduced M1 and M2 macrophages and diminished PD-1-expressing
lymphocytes. PLoS ONE 12(4): e0175563 2017;.
14. Curigliano G, Burstein H J, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan M M,
Piccart-Gebhart M, Senn H J, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Y Brucker
S, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P,
Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes D F, Huang C S, Huober J,
Seite 11 von 41Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne K C, Pagani O,
Partridge A H, Pritchard K, Ro J, Rutgers E J T, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi
M, Tutt A, Viale G, Watanabe T, Whelan T J, Xu B. De-escalating and escalating treatments for
early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the
Primary Therapy of Early Breast Cancer 2017. Ann Oncol 2017; 28:1700-1712.
15. Curigliano G, Burstein H J, Winer E P, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan M M,
Piccart-Gebhart M, Senn H J, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker S
Y, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P,
Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes D F, Huang C S, Huober J,
Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne K C, Pagani O,
Partridge A H, Pritchard K, Ro J, Rutgers E J T, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi
M, Tutt A, Viale G, Watanabe T, Whelan T J, Xu B. Reply to "The St. Gallen International Expert
Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an
International Panel of Experts in Radiation Oncology" by Kirova et al. Ann Oncol 2017;.
16. Delaunay M, Cadranel J, Lusque A, Meyer N, Gounant V, Moro-Sibilot D, Michot J M, Raimbourg
J, Girard N, Guisier F, Planchard D, Metivier A C, Tomasini P, Dansin E, Pérol M, Campana M,
Gautschi O, Früh M, Fumet J D, Audigier-Valette C, Couraud S, Dalle S, Leccia M T, Jaffro M,
Collot S, Prévot G, Milia J, Mazières J. Immune-checkpoint inhibitors associated with interstitial
lung disease in cancer patients. Eur Respir J 2017; 50:.
17. Diem S, Hasan Ali O, Ackermann C J, Bomze D, Koelzer V H, Jochum W, Speiser D E, Mertz K
D, Flatz L. Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma
correspond to response and survival in nine patients treated with ipilimumab at the time of stage
IV disease. Cancer Immunol Immunother 2017; 67:39-45.
18. Diem S, Schmid S, Krapf M, Flatz L, Born D, Jochum W, Templeton A J, Früh M. Neutrophil-to-
Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients
with non-small cell lung cancer (NSCLC) treated with nivolumab. Lung Cancer 2017; 111:176-
181.
19. Droz J P, Albrand G, Gillessen Sommer S, Hughes S, Mottet N, Oudard S, Payne H, Puts M,
Zulian G, Balducci L, Aapro M. Management of Prostate Cancer in Elderly Patients:
Recommendations of a Task Force of the International Society of Geriatric Oncology. Eur Urol
2017; 72:521-531.
20. Endt K, Goepfert J, Omlin A, Athanasiou A, Tennstedt P, Guenther A, Rainisio M, Engeler D S,
Steuber T, Gillessen Sommer S, Joos T, Schiess R. Development and clinical testing of individual
immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer. PLoS
ONE 2017; 12:e0181557.
21. Ess S M, Herrmann C, Frick H, Krapf M, Cerny T, Jochum W, Früh M. Epidermal growth factor
receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with
advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world
practices. Eur J Cancer Care (Engl) 2017;.
22. Fehr M, Müller J, Knitel M, Fornaro J, Horber D, Koeberle D, cerny t, Gueller U. Early
Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of
Stage III Colorectal Cancer Patients. Clin Colorectal Cancer 2017;.
23. Gachechiladze M, Škarda J, Kolek V, Grygárková I, Langová K, Bouchal J, Kolář Z, Baty F,
Stahel R, Weder W, Soltermann A, Joerger M. Prognostic and predictive value of loss of nuclear
RAD51 immunoreactivity in resected non-small cell lung cancer patients. Lung Cancer 2017;
105:31-38.
24. Gachechiladze M, Škarda J, Soltermann A, Joerger M. RAD51 as a potential surrogate marker
for DNA repair capacity in solid malignancies. Int J Cancer 2017; 141:1286-1294.
25. Gautschi O, Milia J, Filleron T, Wolf J, Carbone D P, Owen D, Camidge R, Narayanan V,
Doebele R C, Besse B, Remon-Masip J, Jänne P A, Awad M M, Peled N, Byoung C C, Karp D D,
Van Den Heuvel M, Wakelee H A, Neal J W, Mok T S K, Yang J C H, Ou S H I, Pall G, Froesch
P, Zalcman G, Gandara D R, Riess J W, Velcheti V, Zeidler K, Diebold J, Früh M, Michels S,
Monnet I, Popat S, Rosell R, Karachaliou N, Rothschild S I, Shih J Y, Warth A, Muley T, Cabillic
Seite 12 von 41F, Mazières J, Drilon A. Targeting RET in Patients With RET-Rearranged Lung Cancers: Results
From the Global, Multicenter RET Registry. J Clin Oncol 2017; 35:1403-1410.
26. Gennari A, Sun Z, Hasler-Strub U, Colleoni M, Kennedy M J, von Moos R, Cortes J, Vidal M J,
Hennessy B, Walshe J, Amillano Parraga K, Ribi K, Bernhard J, Morales S M, Pagani O,
Barbeaux A, Borstnar S, Rabaglio-Poretti M, Maibach R, Regan M M, Jerusalem G. A
randomized phase II study evaluating different maintenance schedules of nab-Paclitaxel in the
first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP
trial. Ann Oncol 2017;.
27. Gillessen Sommer S, Attard G, Beer T M, Beltran H, Bossi A, Bristow R, Carver B, Castellano D,
Chung B H, Clarke N, Daugaard G, Davis I D, de Bono J, Dos Reis R B, Drake C G, Eeles R,
Efstathiou E, Evans C P, Fanti S, Feng F, Fizazi K, Frydenberg M, Gleave M, Halabi S,
Heidenreich A, Higano C S, James N, Kantoff P, Kellokumpu-Lehtinen P L, Khauli R B, Kramer
G, Logothetis C, Maluf F, Morgans A K, Morris M J, Mottet N, Murthy V, Oh W, Ost P, Padhani A
R, Parker C, Pritchard C C, Roach M, Rubin M A, Ryan C, Saad F, Sartor O, Scher H, Sella A,
Shore N, Smith M, Soule H, Sternberg C N, Suzuki H, Sweeney C, Sydes M R, Tannock I,
Tombal B, Valdagni R, Wiegel T, Omlin A. Management of Patients with Advanced Prostate
Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur
Urol 2017;.
28. Gillessen Sommer S, de Bono J S, Sartor O, Omlin A. Reply to Finn E. von Eyben, Irene Virgolini
and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M.
Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the
Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol. In press.
http://dx.doi.org/10.1016/j.eururo.2017.06.002. Eur Urol 2017;.
29. Glatzer M, Rittmeyer A, Müller J, Opitz I, Früh M, Papachristofilou A, Psallidas I, Born D, Putora
P M. Treatment of limited disease small cell lung cancer: the multidisciplinary team. European
Respiratory Journal 2017;.
30. Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora
P M. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J
2017; 50:.
31. Gobba S, Moccia A A, Gulden-Sala W, Conconi A, Diem S, Cascione L, Iacoboni G, Margiotta-
Casaluci G, Aprile von Hohenstaufen K, Stathis A, Hitz F, Pinotti G, Gaidano G, Zucca E.
Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with
"standard" immunochemotherapy: A large retrospective study from 4 institutions. Hematol Oncol
2017;.
32. Gueller U, Warschkow R, Ackermann C J, Schmied B, Cerny T, Ess S. Lower hospital volume is
associated with higher mortality after oesophageal, gastric, pancreatic and rectal cancer
resection. Swiss Med Wkly 2017; 147:w14473.
33. Hamzic S, Kummer D, Milesi S, Mueller D, Joerger M, Aebi S, Amstutz U, Largiader C R. Novel
Genetic Variants in Carboxylesterase 1 Predict Severe Early-Onset Capecitabine-Related
Toxicity. Clin Pharmacol Ther 2017; 102:796-804.
34. Heinrich D, Bektic J, Bergman A M, Caffo O, Cathomas R, Chi K N, Daugaard G, Keizman D,
Kindblom J, Kramer G, Olmos D, Omlin A, Sridhar S S, Tucci M, van Oort I, Nilsson S. The
Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate Cancer. Clin
Genitourin Cancer 2017;.
35. Henrich A, Joerger M, Kraff S, Jaehde U, Huisinga W, Kloft C, Parra-Guillen Z P.
Semimechanistic Bone Marrow Exhaustion Pharmacokinetic/Pharmacodynamic Model for
Chemotherapy-Induced Cumulative Neutropenia. J Pharmacol Exp Ther 2017; 362:347-358.
36. Hui D, Cherny N, Latino N, Strasser F. The 'critical mass' survey of palliative care programme at
ESMO designated centres of integrated oncology and palliative care. Ann Oncol 2017; 28:2057-
2066.
37. Hui D, Mori M, Meng Y C, Watanabe S M, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P,
Kaasa S, Bruera E. Automatic referral to standardize palliative care access: an international
Delphi survey. Support Care Cancer 2017;.
Seite 13 von 4138. James N D, de Bono J S, Spears M R, Clarke N W, Mason M D, Dearnaley D P, Ritchie A W S,
Amos C L, Gilson C, Jones R J, Matheson D, Millman R, Attard G, Chowdhury S, Cross W R,
Gillessen Sommer S, Parker C C, Russell J M, Berthold D R, Brawley C, Adab F, Aung S, Birtle A
J, Bowen J, Brock S, Chakraborti P, Ferguson C, Gale J, Gray E, Hingorani M, Hoskin P J, Lester
J F, Malik Z I, McKinna F, McPhail N, Money-Kyrle J, O'Sullivan J, Parikh O, Protheroe A,
Robinson A, Srihari N N, Thomas C, Wagstaff J, Wylie J, Zarkar A, Parmar M K B, Sydes M R,
STAMPEDE Investigators . Abiraterone for Prostate Cancer Not Previously Treated with
Hormone Therapy. N Engl J Med 2017; 377:338-351.
39. Joerger M, Kraff S, Jaehde U, Hilger R A, Courtney J B, Cline D J, Jog S, Baburina I, Miller M C,
Salamone S J. Validation of a Commercial Assay and Decision Support Tool for Routine
Paclitaxel Therapeutic Drug Monitoring (TDM). Ther Drug Monit 2017; 39:617-624.
40. Keizman D, Fosboel M O, Reichegger H, Peer A, Rosenbaum E, Desax M C, Neiman V,
Petersen P M, Mueller J, Cathomas R, Gottfried M, Dresler H, Sarid D, Mermershtain W,
Rouvinov K, Mortensen J, Gillessen Sommer S, Daugaard G, Omlin A. Imaging response during
therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of
an international multicenter database. Prostate Cancer Prostatic Dis 2017; 20:289-293.
41. Klingbiel D, Thürlimann B, Brauchli P, von Moos R. Absence of Evidence is not Evidence of
Absence: The Case of Non-Inferiority. Ann Oncol 2017;.
42. Le Moigne R, Aftab B T, Djakovic S, Dhimolea E, Valle E, Murnane M, King E M, Soriano F,
Menon M K, Wu Z Y, Wong S T, Lee G J, Yao B, Wiita A P, Lam C, Rice J, Wang J, Chesi M,
Bergsagel P L, Kraus M, Driessen C, Kiss von Soly S, Yakes F M, Wustrow D, Shawver L, Zhou
H J, Martin T G, Wolf J L, Mitsiades C S, Anderson D J, Rolfe M. The p97 Inhibitor CB-5083 Is a
Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma. Mol Cancer Ther 2017;
16:2375-2386.
43. Ludwig H, Delforge M, Facon T, Einsele H, Gay F, Moreau P, Avet-Loiseau H, Boccadoro M,
Hajek R, Mohty M, Cavo M, Dimopoulos M A, San-Miguel J F, Terpos E, Zweegman S, Garderet
L, Mateos M V, Cook G, Leleu X, Goldschmidt H, Jackson G, Kaiser M, Weisel K, van de Donk N
W C J, Waage A, Beksac M, Mellqvist U H, Engelhardt M, Caers J, Driessen C, Sonneveld P.
Prevention and management of adverse events of Novel agents in multiple myeloma: A
consensus of the european myeloma network. Leukemia 2017;.
44. Morganstein D L, Lai Z, Spain L, Diem S, Levine D, Mace C, Gore M, Larkin J. Thyroid
abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death
receptor protein-1 inhibitors in the treatment of melanoma. Clin Endocrinol (Oxf) 2017; 86:614-
620.
45. Mottet N, De Santis M, Briers E, Bourke L, Gillessen Sommer S, Grummet J P, Lam T B, van der
Poel H G, Rouvière O, van den Bergh R C N, Cornford P. Updated Guidelines for Metastatic
Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another
Standard. Eur Urol 2017;.
46. Panje C, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L,
Putora P M. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms
analysis. BMC Med Res Methodol 2017; 17:123.
47. Parra-Guillen Z P, Berger P B, Haschke M, Donzelli M, Winogradova D, Pfister B, Früh M,
Gillessen Sommer S, Krähenbühl S, Kloft C, Joerger M. Role of Cytochrome P450 3A4 and 1A2
Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib
Treatment. Basic Clin Pharmacol Toxicol 2017; 121:309-315.
48. Peters S, Gettinger S, Johnson M L, Jänne P A, Garassino M C, Christoph D, Toh C K, Rizvi N A,
Chaft J E, Carcereny Costa E, Patel J D, Chow L Q M, Koczywas M, Ho C, Früh M, van den
Heuvel M, Rothenstein J, Reck M, Paz-Ares L, Shepherd F A, Kurata T, Li Z, Qiu J, Kowanetz M,
Mocci S, Shankar G, Sandler A, Felip E. Phase II Trial of Atezolizumab As First-Line or
Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-
Small-Cell Lung Cancer (BIRCH). J Clin Oncol 2017; 35:2781-2789.
49. Pettersen K, Andersen S, Degen S, Tadini V, Grosjean J, Hatakeyama S, Tesfahun A N,
Moestue S, Kim J, Nonstad U, Romundstad P R, Skorpen F, Sørhaug S, Amundsen T, Grønberg
Seite 14 von 41B H, Strasser F, Stephens N, Hoem D, Molven A, Kaasa S, Fearon K, Jacobi C, Bjørkøy G.
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-
derived IL-6 trans-signaling. Sci Rep 2017; 7:2046.
50. Pezaro C J, Omlin A, Mastris K, Attard G, Beer T M, Chi K N, Chowdhury S, Davis I D, Drake C
G, de Bono J S, Efstathiou E, Gravis G, Higano C S, Hussain M, James N, Logothetis C J,
Morgans A, Parker C, Ryan C J, Saad F, Sartor O, Small E J, Sternberg C N, Sweeney C J,
Tannock I, Tombal B, Gillessen Sommer S. Precision, complexity and stigma in advanced
prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer.
Ann Oncol 2017; 28:1692-1694.
51. Prior J O, Gillessen Sommer S, Wirth M, Dale W, Aapro M, Oyen W J G. Radiopharmaceuticals
in the elderly cancer patient: Practical considerations, with a focus on prostate cancer therapy: A
position paper from the International Society of Geriatric Oncology Task Force. Eur J Cancer
2017; 77:127-139.
52. Renz M, Reichmuth O, Bueche D, Traichel B, Mao M S, Cerny T, Strasser F. Fear, Pain, Denial,
and Spiritual Experiences in Dying Processes. Am J Hosp Palliat Care 2017;1049909117725271.
53. Renz M. Fear, pain, denial and spiritual expereinces in dying processes. Am J Hosp Care 2017;.
54. Renz M. In der Frage bleiben: Aufgezeichnet und fotografiert von C. Klein. Ferment 2017;
Bildband:28-31.
55. Renz M. Wissenschaft auf den Punkt gebracht: Sterben als Übergang. Psychotherapie &
Seelsorge 2017; Themenheft: Denkräume:.
56. Ribi K, Rondeau S, Hitz F, Mey U, Enoiu M, Pabst T, Stathis A, Fischer N, Clough-Gorr K M.
Cancer-specific geriatric assessment and quality of life: important factors in caring for older
patients with aggressive B-cell lymphoma. Support Care Cancer 2017; 25:2833-2842.
57. Rosell R, Dafni U, Felip E, Curioni-Fontecedro A, Gautschi O, Peters S, Massutí B, Palmero R,
Aix S P, Carcereny E, Früh M, Pless M, Popat S, Kotsakis A, Cuffe S, Bidoli P, Favaretto A,
Froesch P, Reguart N, Puente J, Coate L, Barlesi F, Rauch D, Thomas M, Camps C, Gómez-
Codina J, Majem M, Porta R, Shah R, Hanrahan E, Kammler R, Ruepp B, Rabaglio M,
Kassapian M, Karachaliou N, Tam R, Shames D S, Molina-Vila M A, Stahel R A, BELIEF
collaborative group . Erlotinib and bevacizumab in patients with advanced non-small-cell lung
cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase
2 trial. Lancet Respir Med 2017; 5:435-444.
58. Rothermundt C, Fischer G, Bauer S, Blay J Y, Grünwald V, Italiano A, Kasper B, Kollár A,
Lindner L H, Miah A, Sleijfer S, Stacchiotti S, Putora P M. Pre- and Postoperative Chemotherapy
in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and
Treatment of Cancer Expert Survey. Oncologist 2017;.
59. Schnegg-Kaufmann A, Feller A, Baldomero H, Rovo A, Manz M G, Gregor M, Efthymiou A,
Bargetzi M, Hess U, Spertini O, Chalandon Y, Passweg J R, Stussi G, Arndt V, Bonadies N,
NICER Working Group . Improvement of relative survival in elderly patients with acute myeloid
leukaemia emerging from population-based cancer registries in Switzerland between 2001 and
2013. Cancer Epidemiol 2017; 52:55-62.
60. Seddon B, Strauss S J, Whelan J, Leahy M, Woll P J, Cowie F, Rothermundt C, Wood Z, Benson
C, Ali N, Marples M, Veal G J, Jamieson D, Küver K, Tirabosco R, Forsyth S, Nash S, Dehbi H M,
Beare S. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously
untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised
controlled phase 3 trial. Lancet Oncol 2017;.
61. Siano M, Infante G, Resteghini C, Cau M C, Alfieri S, Bergamini C, Granata R, Miceli R, Locati L,
Licitra L, Bossi P. Outcome of recurrent and metastatic head and neck squamous cell cancer
patients after first line platinum and cetuximab therapy. Oral Oncol 2017; 69:33-37.
62. Siano M, Molinari F, Martin V, Mach N, Früh M, Freguia S, Corradino I, Ghielmini M, Frattini M,
Espeli V. Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head
and Neck Squamous Cell Cancer. Oncologist 2017;.
63. Skrott Z, Mistrik M, Andersen K K, Friis S, Majera D, Gursky J, Ozdian T, Bartkova J, Turi Z,
Moudry P, Kraus M, Michalova M, Vaclavkova J, Dzubak P, Vrobel I, Pouckova P, Sedlacek J,
Seite 15 von 41Miklovicova A, Kutt A, Li J, Mattova J, Driessen C, Dou Q P, Olsen J, Hajduch M, Cvek B,
Deshaies R J, Bartek J. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor
NPL4. Nature 2017; 552:194-199.
64. Stathis A, Hess D, von Moos R, Homicsko K, Griguolo G, Joerger M, Mark M, Ackermann C J,
Allegrini S, Catapano C V, Xyrafas A, Enoiu M, Berardi S, Gargiulo P, Sessa C, Swiss Group for
Clinical Cancer Research (SAKK). Phase I trial of the oral smoothened inhibitor sonidegib in
combination with paclitaxel in patients with advanced solid tumors. Invest New Drugs 2017;
35:766-772.
65. Tandstad T, Kollmannsberger C K, Roth B J, Jeldres C, Gillessen Sommer S, Fizazi K,
Daneshmand S, Lowrance W T, Hanna N H, Albany C, Foster R, Cedermark G C, Feldman D R,
Powles T, Lewis M A, Grimison P S, Bank D, Porter C, Albers P, De Santis M, Srinivas S, Bosl G
J, Nichols C R. Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model
Curable Neoplasm. J Clin Oncol 2017; 35:3525-3528.
66. Tarantino I, Warschkow R, Gueller U. Palliative Primary Tumor Resection in Patients With
Metastatic Colorectal Cancer: For Whom and When? Ann Surg 2017; 265:e59-e60.
67. Vagnildhaug O M, Blum D, Wilcock A, Fayers P, Strasser F, Baracos V E, Hjermstad M J, Kaasa
S, Laird B, Solheim T S. The applicability of a weight loss grading system in cancer cachexia: a
longitudinal analysis. J Cachexia Sarcopenia Muscle 2017;.
68. Viehl C T, Weixler B, Gueller U, Dell-Kuster S, Rosenthal R, Ramser M, Banz V, Langer I,
Terracciano L, Sauter G, Oertli D, Zuber M. Presence of bone marrow micro-metastases in stage
I-III colon cancer patients is associated with worse disease-free and overall survival. Cancer Med
2017; 6:918-927.
69. Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary
tumours: challenges and approaches, a review. ESMO Open 2017; 2:e000172.
70. Warschkow R, Gueller U, Cerny T, Schmied B, Plasswilm L, Putora P M. Secondary
malignancies after rectal cancer resection with and without radiation therapy: A propensity-
adjusted, population-based SEER analysis. Radiother Oncol 2017; 123:139-146.
71. Weber W P, Soysal S D, El-Tamer M, Sacchini V, Knauer M, Tausch C, Hauser N, Günthert A,
Harder Y, Kappos E A, Schwab F, Fitzal F, Dubsky P, Bjelic-Radisic V, Reitsamer R, Koller R,
Heil J, Hahn M, Blohmer J U, Hoffmann J, Solbach C, Heitmann C, Gerber B, Haug M, Kurzeder
C. First international consensus conference on standardization of oncoplastic breast conserving
surgery. Breast Cancer Res Treat 2017; 165:139-149.
72. Weixler B, Rickenbacher A, Raptis D A, Viehl C T, Gueller U, Rueff J, Zettl A, Zuber M. Sentinel
Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows
Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-
Center Trial. World J Surg 2017; 41:2378-2386.
73. Weixler B, Viehl C T, Warschkow R, Gueller U, Ramser M, Sauter R, Zuber M. Comparative
Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in
Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study. JAMA Surg
2017;.
74. Zander T, Aebi S, Pabst T, Renner C, Driessen C. Spotlight on pomalidomide: could less be
more? Leukemia 2017; 31:1987-1989.
75. Zweifel M, Thürlimann B, Riniker S, Weder P, von Moos R, Pagani O, Bigler M, Rothgiesser K M,
Pilop C, Hawle H, Brauchli P, Tapia C, Schoenfeld W, Sessa C. Phase I trial of the androgen
receptor modulator CR1447 in breast cancer patients. Endocr Connect 2017; 6:549-556.
Pneumologie/Schlafmedizin
Wissenschaftliche Artikel
1. Annaheim S, Camenzind M, Schoch O, Brutsche M, Baty F, Rossi R. Session 59. Biosignal
processing and monitoring IV. Biomed Tech (Berl) 2017; 62:s526-s530.
Seite 16 von 41Sie können auch lesen
